These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33609603)

  • 1. Melancholic features in major depression - a European multicenter study.
    Dold M; Bartova L; Fugger G; Kautzky A; Mitschek MMM; Fabbri C; Montgomery S; Zohar J; Souery D; Mendlewicz J; Serretti A; Kasper S
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Aug; 110():110285. PubMed ID: 33609603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Add-on benzodiazepine treatment in patients with major depressive disorder - results from a European cross-sectional multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MMM; Kautzky A; Frey R; Montgomery S; Zohar J; Mendlewicz J; Souery D; Fabbri C; Serretti A; Kasper S
    Eur Neuropsychopharmacol; 2020 Dec; 41():70-80. PubMed ID: 33046351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report.
    Bobo WV; Chen H; Trivedi MH; Stewart JW; Nierenberg AA; Fava M; Kurian BT; Warden D; Morris DW; Luther JF; Husain MM; Cook IA; Lesser IM; Kornstein SG; Wisniewski SR; Rush AJ; Shelton RC
    J Affect Disord; 2011 Oct; 133(3):467-76. PubMed ID: 21601287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sociodemographic and clinical profile of patients with major depressive disorder receiving SSRIs as first-line antidepressant treatment in European countries.
    Fugger G; Bartova L; Fabbri C; Fanelli G; Dold M; Swoboda MMM; Kautzky A; Zohar J; Souery D; Mendlewicz J; Montgomery S; Rujescu D; Serretti A; Kasper S
    Eur Arch Psychiatry Clin Neurosci; 2022 Jun; 272(4):715-727. PubMed ID: 34989830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin augmentation of antidepressants in major depression - results from a European multicenter study.
    Dold M; Bartova L; Fugger G; Mitschek MM; Fabbri C; Serretti A; Mendlewicz J; Souery D; Zohar J; Montgomery S; Kasper S
    J Affect Disord; 2022 Jan; 296():485-492. PubMed ID: 34653701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological treatment strategies in unipolar depression in European tertiary psychiatric treatment centers - A pharmacoepidemiological cross-sectional multicenter study.
    Dold M; Kautzky A; Bartova L; Rabl U; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1960-1971. PubMed ID: 27816317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical factors associated with augmentation treatment with second-generation antipsychotics and lithium in major depression - Results from a European multicenter study.
    Dold M; Bartova L; Kautzky A; Serretti A; Porcelli S; Souery D; Mendlewicz J; Montgomery S; Zohar J; Kasper S
    Eur Neuropsychopharmacol; 2018 Dec; 28(12):1305-1313. PubMed ID: 30446357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression.
    Dold M; Bartova L; Kautzky A; Porcelli S; Montgomery S; Zohar J; Mendlewicz J; Souery D; Serretti A; Kasper S
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30677267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and clinical features and prescribing patterns of psychotropic medications in patients with the melancholic subtype of major depressive disorder in China.
    Xiang YT; Wang G; Hu C; Guo T; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Zheng QW; Chen DF; Fang YR; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
    PLoS One; 2012; 7(6):e39840. PubMed ID: 22768140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of augmentation/combination treatment strategies in major depressive disorder.
    Dold M; Bartova L; Mendlewicz J; Souery D; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Acta Psychiatr Scand; 2018 May; 137(5):401-412. PubMed ID: 29492960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melancholic features and treatment outcome to selective serotonin reuptake inhibitors in major depressive disorder: A re-analysis of the STAR*D trial.
    Szmulewicz A; Valerio MP; Lomastro J; Martino DJ
    J Affect Disord; 2024 Feb; 347():101-107. PubMed ID: 37981037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of comorbid post-traumatic stress disorder in patients with major depressive disorder on clinical features, pharmacological treatment strategies, and treatment outcomes - Results from a cross-sectional European multicenter study.
    Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Porcelli S; Zohar J; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2017 Jul; 27(7):625-632. PubMed ID: 28579072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A quantitative review on outcome-to-antidepressants in melancholic unipolar depression.
    Valerio MP; Szmulewicz AG; Martino DJ
    Psychiatry Res; 2018 Jul; 265():100-110. PubMed ID: 29702301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to antidepressants in major depressive disorder with melancholic features: the CRESCEND study.
    Yang SJ; Stewart R; Kang HJ; Kim SY; Bae KY; Kim JM; Jung SW; Lee MS; Yim HW; Jun TY
    J Affect Disord; 2013 Jan; 144(1-2):42-50. PubMed ID: 22840632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of antidepressant drugs in schizophrenic patients with depression].
    Micallef J; Fakra E; Blin O
    Encephale; 2006; 32(2 Pt 1):263-9. PubMed ID: 16910628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbid hypertension in patients with major depressive disorder - Results from a European multicenter study.
    Fugger G; Dold M; Bartova L; Kautzky A; Souery D; Mendlewicz J; Serretti A; Zohar J; Montgomery S; Frey R; Kasper S
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):777-785. PubMed ID: 31006562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of painful physical symptoms in the treatment of Japanese patients with melancholic major depressive disorder: A prospective cohort study.
    Sekine A; Hozumi S; Shimizu T
    Psychiatry Res; 2016 Aug; 242():240-244. PubMed ID: 27294798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of SSRIs and newer antidepressants in severe depression: comparison with TCAs.
    Hirschfeld RM
    J Clin Psychiatry; 1999 May; 60(5):326-35. PubMed ID: 10362442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low comorbid obsessive-compulsive disorder in patients with major depressive disorder - Findings from a European multicenter study.
    Dold M; Bartova L; Souery D; Mendlewicz J; Porcelli S; Serretti A; Zohar J; Montgomery S; Kasper S
    J Affect Disord; 2018 Feb; 227():254-259. PubMed ID: 29107818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.